Biocryst Pharmaceuticals (BCRX) Free Cash Flow: 2010-2015
Historic Free Cash Flow for Biocryst Pharmaceuticals (BCRX) over the last 5 years, with Dec 2015 value amounting to -$18.9 million.
- Biocryst Pharmaceuticals' Free Cash Flow fell 35.25% to -$18.9 million in Q4 2015 from the same period last year, while for Dec 2015 it was -$18.2 million, marking a year-over-year increase of 52.82%. This contributed to the annual value of -$53.1 million for FY2024, which is 45.39% up from last year.
- Per Biocryst Pharmaceuticals' latest filing, its Free Cash Flow stood at -$18.9 million for Q4 2015, which was down 47.43% from -$12.8 million recorded in Q3 2015.
- In the past 5 years, Biocryst Pharmaceuticals' Free Cash Flow registered a high of $17.7 million during Q2 2015, and its lowest value of -$18.9 million during Q4 2015.
- Over the past 3 years, Biocryst Pharmaceuticals' median Free Cash Flow value was -$8.3 million (recorded in 2013), while the average stood at -$7.0 million.
- In the last 5 years, Biocryst Pharmaceuticals' Free Cash Flow crashed by 208.81% in 2014 and then surged by 349.63% in 2015.
- Quarterly analysis of 5 years shows Biocryst Pharmaceuticals' Free Cash Flow stood at -$4.0 million in 2011, then crashed by 76.36% to -$7.0 million in 2012, then skyrocketed by 35.70% to -$4.5 million in 2013, then crashed by 208.81% to -$14.0 million in 2014, then tumbled by 35.25% to -$18.9 million in 2015.
- Its last three reported values are -$18.9 million in Q4 2015, -$12.8 million for Q3 2015, and $17.7 million during Q2 2015.